← Open Payments lookup

LEO MEDINA: Open Payments

NPI 1972967875 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$673 in 26 payments from 11 companies in 2025. Trend: 2023 $116 · 2024 $518 · 2025 $673

Food & beverage: $673
CompanyPaymentsAmount
Actelion Pharmaceuticals US, Inc.4$131
Takeda Pharmaceuticals U.S.A., Inc.4$104
BridgeBio Pharma, Inc.3$97
SCPHARMACEUTICALS INC.4$79
Boehringer Ingelheim Pharmaceuticals, Inc.3$77
Astellas Pharma US Inc2$53
CVRx, Inc.2$46
Analog Devices Inc.1$26
PFIZER INC.1$22
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$21

Products named: LIVTENCITY, Attruby, FUROSCIX, UPTRAVI, OPSUMIT, Cresemba, Barostim Neo System, JASCAYD.

Industry payments across TX — which companies pay providers there.